DATE
Merck & Co.’s Keytruda Achieves $7 Billion in Quarterly Sales, Surpassing Expectations
Merck & Co., Keytruda, quarterly sales, Winrevair, pharmaceuticals, oncology
Biopharma Layoff Tracker 2024: Anokion, GlycoMimetics, Relay and More Cut Staff
Biopharma, Layoffs, 2024, Anokion, GlycoMimetics, Relay, Restructuring, Job Cuts, Industry Trends
Ipsen Secures Ex-US Rights to Day One’s Pediatric Cancer Medication with $111M Upfront Investment
Ipsen, Day One, Pediatric Cancer, Tovorafenib, Ex-US Rights, $111M Upfront Investment
Sanofi’s Dupixent Sales Surpass €3 Billion for the First Time
Sanofi, Dupixent, quarterly sales, record high, asthma medicine, earnings forecast
Fierce Biotech Layoff Tracker 2024: Industry-Wide Job Cuts Continue
Biotech Layoffs, 2024, MEI Pharma, Rapt Therapeutics, Industry Cuts
Biopharma Layoff Tracker 2024: Thousands of Jobs Cut Across Industry Giants
Biopharma Layoffs, 2024, Industry Giants, Job Cuts, Restructuring, Cost Savings
Johnson & Johnson Raises 2024 Guidance Following Acquisition of Shockwave Medical
Johnson & Johnson, Shockwave Medical, 2024 Guidance, Acquisition, Billion-Dollar Potential
How the world’s biggest pharma and biotech companies paid their typical worker in 2023
2023, Midline (qualifier value), Gilead, Wages, Average, Highest
How the world’s biggest pharma and biotech companies paid their typical worker in 2023
Dosage Forms, Industry, world ‘s, Worker, 2023